Business

Former Pfizer Employee Charged With Insider Trading

Washington [US]: Financial regulator in the US announced it charged insider trading against Amit Dagar, a former Pfizer Inc. employee, and his close friend and business partner, Atul Bhiwapurkar, for trading in advance in November 2021 based on inside information that the study of its Covid-19 antiviral treatment, Paxlovid, was successful.

Following that announcement in which Pfizer’s CEO referred to the news as a “game-changer” in the global efforts to “halt the devastation” of the pandemic, the company’s stock price increased by nearly 11 per cent, the largest single-day price move in the stock since 2009. Insider trading generally refers to buying or selling a stock or any financial assets on the basis of material, non-public information about them.

According to the regulator Securities and Exchange Commission’s complaint, Dagar was a senior statistical program lead for the Paxlovid drug trial, which began in July 2021 as part of the company’s efforts to address the global health pandemic.

On the day before the Paxlovid announcement, the complaint alleges, Dagar learned about the material, nonpublic information about the success of the trial. Specifically, the SEC alleged that Dagar’s supervisor informed him via chat that “we got the outcome,” there was a “lot of work lined up,” and that there would be a “press release tomorrow,” to which Dagar responded with “oh really” and “kind of exciting”, SEC said today in a statement.
The complaint alleged that Dagar’s and Bhiwapurkar’s trading generated approximately USD 214,395 and USD 60,300 respectively in illicit profits, which amounted to one-day investment returns of whopping 2,458 percent and 791 per cent.

The case originated from the SEC’s Market Abuse Unit’s Analysis and Detection Center, which uses data analysis tools to detect suspicious trading patterns.

“As alleged in our complaint, Amit Dagar misused his access to confidential clinical trial results to enrich himself and his friend, Atul Bhiwapurkar,” said Joseph Sansone, Chief of the Market Abuse Unit.

“Dagar and Bhiwapurkar allegedly leveraged this information by trading out-of-the-money call options to generate massive one-day returns. Thanks to our surveillance, the defendants must now face the consequences of their greed,” he added.

The SEC’s complaint, filed in US District Court for the Southern District of New York, charges Dagar and Bhiwapurkar with violating the antifraud provisions of “Section 10(b) of the Securities Exchange Act of 1934 and Exchange Act Rule 10b-5 thereunder and seeks injunctive relief, disgorgement with prejudgment interest, and civil penalties”.

Parallely, the U.S. Attorney’s Office for the Southern District of New York today announced criminal charges against Dagar and Bhiwapurkar, SEC said in the statement.

Admin

Recent Posts

Charlie Woods Stuns with Hole-In-One, Tiger Woods’ Celebration Steals the Show

15-year-old Charlie Woods amazes the golf world with a perfect hole-in-one, lifting Team Woods into…

6 minutes ago

SA Skipper Bavuma Disappointed After Series Whitewash By Pakistan

December 23, 2024: South African cricket finds itself at a crossroads following a historic 3-0…

9 minutes ago

Pune Tragedy: Drunk Truck Driver Runs Over Sleeping Labourers, 3 Dead Including 2 Toddlers

A horrific accident in Pune's Wagholi area claims three lives, including two children, as a…

12 minutes ago

“Just Trying To Put Pressure Back On The Bowlers..” Australia’s Sam Konstas On His Plans Against Bumrah

December 23, 2024: Sam Konstas' rise to the Australian national team is a compelling story…

48 minutes ago

Libra 2025 Horoscope: A Year of Harmony and Bold Decisions

Libra (September 23 – October 22): The year 2025 is one of balance, growth, and…

53 minutes ago

Jairam Ramesh Criticizes GST Council Over Multiple Popcorn Tax Slabs

Congress Leader Calls GST System Overly Complex, Highlights Loopholes and Compliance Issues New Delhi, December…

55 minutes ago